The GLP-1 Oral Revolution Faces the Adherence Wall
The needle is dying. The pill is here. The patient is failing.Pharmaceutical giants are pivotting. Novo Nordisk and Eli Lilly…
The needle is dying. The pill is here. The patient is failing.Pharmaceutical giants are pivotting. Novo Nordisk and Eli Lilly…
The Equity PivotThe cranes are back. Mumbai’s skyline is a forest of steel. For years, India’s real estate developers were…
The Silicon HegemonyThe ceiling just shattered. Emerging market stocks reached a record high today. The MSCI Emerging Markets Index eclipsed…
The era of easy money is dead. It has been dead for years. Yet the ghost of zero-interest rates still…
The greenback is losing its grip.Institutional desks are dumping the dollar. The narrative of American exceptionalism is hitting a wall…
Larry Fink is not subtle.The BlackRock chairman spent the morning in Washington signaling a total pivot toward real assets. The…
The Private Capital Takeover of Public WorksLarry Fink is pivoting. The era of pure digital arbitrage is cooling. Physical reality…
The House Did Not Just WinThe market took the house. On February 10, 2026, the ledger for Super Bowl LIX…
The Hype Cycle Meets the Balance SheetThe honeymoon for AI infrastructure providers is officially over. Investors no longer reward promises…
The Great Rotation Out of Tech Has Found a HomeThe yield curve is flattening. Capital is restless. For three years,…